Sun.Jul 31, 2022

Disparities in United States COVID-19 vaccine distribution

The Pharma Data

When reports showed COVID-19 vaccination rates were lower among racial/ethnic minority groups, most discussions focused on mistrust and misinformation among these populations or their reduced access to health care facilities.

CDRH is NOW Accepting Electronic Submissions

FDA Law Blog

By Allyson B. Mullen — On July 19, 2022, CDRH announced to users of its Customer Collaborations Portal (CCP) that it is now accepting premarket submissions electronically.

52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

The Medical Metaverse Digest for July 2022

Intouch Solutions

Authors: Paris Daniell, Jeff Greene, Andrew Grojean, Alex Kareotes, Jeff MacFarland, Nicole Maksimovic, Sarah Morgan, Rachel Stelmach, Carly Stilwell.

New patent expiration for Sprout Pharms drug ADDYI

Drug Patent Watch

Annual Drug Patent Expirations for ADDYI Addyi is a drug marketed by Sprout Pharms and is included in one NDA. It is available from one supplier. There are four patents…. The post New patent expiration for Sprout Pharms drug ADDYI appeared first on DrugPatentWatch - Make Better Decisions.

2022 Research: The Rapid Rise of Ocean Freight Visibility

Download this a benchmark study from FourKites and The Journal of Commerce exploring how international shippers’ usage of global supply chain visibility technology has evolved since the onset of global disruptions caused by COVID-19.

Syncope and the Risk of Subsequent Motor Vehicle Crash

JAMA Internal Medicine

This cohort study compares the rate of motor vehicle crashes among patients discharged from the emergency department after first-episode syncope vs conditions other than syncope to determine if more stringent driving restrictions are warranted

New patent expiration for NOVO drug MACRILEN

Drug Patent Watch

Annual Drug Patent Expirations for MACRILEN Macrilen is a drug marketed by Novo and is included in one NDA. It is available from two suppliers. There are two patents protecting…. The post New patent expiration for NOVO drug MACRILEN appeared first on DrugPatentWatch - Make Better Decisions.

More Trending

Drugs facing the most patent expirations this year

Drug Patent Watch

Expiring drug patents are continuously driving innovation, as branded firms seek out new high-margin opportunities. Examining the patent expirations by year can indicate which pharmaceutical companies face the most peril….

Wide Complex Tachycardia and Flecainide

JAMA Internal Medicine

This case report describes a patient in their 70s with a history of paroxysmal atrial fibrillation who presented to the emergency department with complaints of dizziness

Drug Patent Expirations for the Week of July 31, 2022

Drug Patent Watch

MACRILEN (macimorelin acetate) Novo Patent: 6,861,409 Expiration: Aug 1, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or…. The post Drug Patent Expirations for the Week of July 31, 2022 appeared first on DrugPatentWatch - Make Better Decisions. Patent Expiration

Drugs 40